Maitreya Medicare Ltd
₹ 113
-4.77%
24 Aug
- close price
About
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]
Key Points
- Market Cap ₹ 76.5 Cr.
- Current Price ₹ 113
- High / Low ₹ 293 / 108
- Stock P/E
- Book Value ₹ 44.6
- Dividend Yield 0.00 %
- ROCE -0.14 %
- ROE -4.63 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 46.4 days to 21.2 days
Cons
- Stock is trading at 2.53 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.52% over past five years.
- Company has a low return on equity of 5.22% over last 3 years.
- Earnings include an other income of Rs.0.73 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 8.40 | 55.73 | 48.14 | 38.38 | 44.85 | 42.74 | 44.22 | |
| 7.74 | 48.42 | 45.21 | 31.22 | 38.69 | 37.86 | 43.63 | |
| Operating Profit | 0.66 | 7.31 | 2.93 | 7.16 | 6.16 | 4.88 | 0.59 |
| OPM % | 7.86% | 13.12% | 6.09% | 18.66% | 13.73% | 11.42% | 1.33% |
| 0.04 | 0.46 | 0.44 | 0.52 | 0.22 | 0.44 | 0.73 | |
| Interest | 0.31 | 0.79 | 0.76 | 0.57 | 0.74 | 0.75 | 1.28 |
| Depreciation | 0.34 | 1.00 | 1.20 | 1.27 | 1.26 | 1.35 | 1.38 |
| Profit before tax | 0.05 | 5.98 | 1.41 | 5.84 | 4.38 | 3.22 | -1.34 |
| Tax % | 220.00% | 26.09% | 24.11% | 28.25% | 27.85% | 40.99% | -0.75% |
| -0.06 | 4.41 | 1.07 | 4.19 | 3.17 | 1.90 | -1.32 | |
| EPS in Rs | -60.00 | 4,410.00 | 1,070.00 | 8.45 | 4.68 | 2.80 | -1.95 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | 5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -170% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -55% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 5% |
| Last Year: | -5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 4.96 | 6.78 | 6.78 | 11.55 |
| Reserves | -0.05 | 4.36 | 5.48 | 3.82 | 18.08 | 19.98 | 18.66 |
| 12.13 | 14.24 | 12.38 | 11.59 | 9.46 | 8.85 | 22.88 | |
| 2.30 | 7.28 | 4.96 | 7.38 | 6.20 | 8.80 | 10.20 | |
| Total Liabilities | 14.39 | 25.89 | 22.83 | 27.75 | 40.52 | 44.41 | 63.29 |
| 9.33 | 13.81 | 13.50 | 11.51 | 10.94 | 11.97 | 33.09 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.41 | 1.54 | 0.36 | 0.70 | 3.61 | 7.63 | 7.62 |
| 4.65 | 10.54 | 8.97 | 15.54 | 25.97 | 24.81 | 22.58 | |
| Total Assets | 14.39 | 25.89 | 22.83 | 27.75 | 40.52 | 44.41 | 63.29 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 1.23 | 4.91 | 0.77 | 2.42 | -0.26 | 5.03 | 5.48 | |
| -12.17 | -5.63 | 0.16 | 0.36 | -5.57 | -7.20 | -22.42 | |
| 11.88 | 1.51 | -2.61 | -1.34 | 10.00 | -1.58 | 17.92 | |
| Net Cash Flow | 0.94 | 0.79 | -1.68 | 1.43 | 4.18 | -3.75 | 0.98 |
| Free Cash Flow | -8.44 | -0.57 | -0.12 | 2.99 | -0.94 | 2.66 | -17.03 |
| CFO/OP | 152% | 78% | 26% | 38% | 25% | 133% | 949% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 31.72 | 30.78 | 40.94 | 88.06 | 106.37 | 129.64 | 95.91 |
| Inventory Days | 171.39 | 62.04 | 40.82 | 69.86 | 29.89 | 29.95 | 29.65 |
| Days Payable | 558.61 | 230.96 | 221.25 | 317.85 | 149.43 | 173.45 | 125.90 |
| Cash Conversion Cycle | -355.50 | -138.13 | -139.49 | -159.93 | -13.18 | -13.87 | -0.34 |
| Working Capital Days | 0.87 | 4.13 | 16.83 | 26.63 | 60.30 | 57.56 | 21.21 |
| ROCE % | 43.19% | 11.40% | 33.68% | 18.61% | 11.30% | -0.14% |
Insights
In beta| Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Bed Capacity beds |
|
||||
| Number of Hospitals hospitals |
|||||
| Number of Specialties specialties |
|||||
| ARPOB (Average Revenue Per Occupied Bed) INR |
|||||
| Bed Occupancy Rate % |
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Shareholders meeting
- Maitreya Medicare's 7th AGM is on 21 Sep 2026; shareholders to adopt FY26 statements and reappoint a director.
-
Record Date
- Record date fixed as 14 September 2026 for the 7th Annual General Meeting.
-
Outcome of Board Meeting
- Board approved 7th AGM on 21 September 2026, book closure, director's report and scrutinizer appointment.
-
Disclosure under SEBI Takeover Regulations
- Maitreya Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, …
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended June 30, 2026.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
Sep 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
Business Overview:[1]
MML is a Surat-based multi-super speciality hospital with a 125-bed capacity and a 50-bed capacity in its subsidiary, Tulip Health Check. Its facility offers a wide range of integrated healthcare services, spanning primary, secondary, and tertiary care. These
include Gastroenterology, Nephrology, General & Laparoscopic Surgery, Urology, Oncology, Oncosurgery, Gynecology and High-Risk Obstetrics, Emergency & Trauma, Cardiology, Orthopedic & Joint Replacement Surgery, Cardiothoracic and Vascular Surgery, Neurology, Critical Care Medicine, Neurosurgery, Spine Surgery, Gastrointestinal Surgery, and Cardiothoracic Surgery, Orthopedic Surgery (Including Joint Replacements and Arthroscopic Surgeries), Hepatocellular Biliary Surgery, etc.